TITLE

Seasonal congestive heart failure mortality and hospitalisation trends, Quebec 1990-1998

AUTHOR(S)
Feldman, D. Ehrmann; Platt, R.; Déry, V.; Kapetanakis, C.; Lamontagne, D.; Ducharme, A.; Giannetti, N.; Frenette, M.; Beck, E. J.
PUB. DATE
February 2004
SOURCE
Journal of Epidemiology & Community Health;Feb2004, Vol. 58 Issue 2, p129
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
STUDY OBJECTIVE: To describe seasonal congestive heart failure (CHF) mortality and hospitalisations in Quebec, Canada between 1990-1998 and compare trends in CHF mortality and morbidity with those in France. DESIGN: Population cohort study. SETTING: Province of Quebec, Canada. PATIENTS: Mortality data were obtained from the Quebec Death Certificate Registry and hospitalisation from the Quebec Med-Echo hospital discharge database. Cases with primary ICD-9 code 428 were considered cases of CHF. RESULTS: Monthly CHF mortality was higher in January, declined until September and then rose steadily (p<0.05). Hospital admissions for CHF declined from May until September (moving averages analysis p<0.0001). Seasonal mortality patterns observed in Quebec were similar to those observed in France. CONCLUSION: CHF mortality in Quebec is highest during the winter and declines in the summer, similar to observations in France and Scotland. This suggests that absolute temperatures may not necessarily be that important but increased CHF mortality is observed once environmental temperatures fall below a certain "threshold" temperature. Alternatively better internal heating and warmer clothing required for survival in Quebec may ameliorate mortality patterns despite colder external environments.
ACCESSION #
12136893

 

Related Articles

  • Risk of death after first admission for cardiovascular diseases by country of birth in The Netherlands: a nationwide record-linked retrospective cohort study. C Agyemang // Heart;May2009, Vol. 95 Issue 9, p747 

    OBJECTIVE: To examine differences in short- (28 days) and long-term (5 years) risk of death in patients hospitalised for the first time for various cardiovascular diseases (CVD) by country of birth and/or parental country of birth. DESIGN: A nationwide prospective cohort of CVD patients....

  • Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Ng, T.P.; Niti, M. // Heart;Aug2003, Vol. 89 Issue 8, p865 

    Objectives: To describe trends in hospital admissions and mortality from congestive heart failure in the elderly population aged 65 years and over in Singapore, 1991 to 1998. Design: Analysis of trends and population subgroup differences in rates of hospital admission and mortality for a primary...

  • Digoxin and mortality in atrial fibrillation: a prospective cohort study. Hallberg, Pär; Lindbäck, Johan; Lindahl, Bertil; Stenestrand, Ulf; Melhus, Håkan // European Journal of Clinical Pharmacology;Oct2007, Vol. 63 Issue 10, p959 

    The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study showed that rhythm-control treatment of patients with atrial fibrillation (AF) offered no survival advantage over a rate-control strategy. In a subgroup analysis of that study, it was found that digoxin increased...

  • Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission. Glasgow, Justin M.; Vaughn-Sarrazin, Mary; Kaboli, Peter J. // JGIM: Journal of General Internal Medicine;Sep2010, Vol. 25 Issue 9, p926 

    Background: With 1-2% of patients leaving the hospital against medical advice (AMA), the potential for these patients to suffer adverse health outcomes is of major concern.Objective: To examine 30-day hospital readmission and mortality rates for medical patients who...

  • ...-blockade saves lives in congestive heart failure. Pinkowish, Mary Desmond // Patient Care;10/15/1997, Vol. 31 Issue 16, p171 

    Reports that according to a meta-analysis, ...-blockade may offer significant mortality reductions to patients with chronic congestive heart failure (CHF). Description of experiments conducted in study; Odds of death; Speculations on the influence of ...-blockers delay on CHF.

  • COMMENTARY. Meisner, Jay S. // Evidence Based Medicine;Sep2003, p157 

    The author reflects on the significance of the study which illustrates that diastolic dysfunction is prevalent and leading cause of congestive heart failure (CHF).

  • AHRQ reports sharp drop in some inpatient mortality rates.  // AHA News;10/15/2007, Vol. 43 Issue 21, p8 

    The article discusses the U.S. Agency for Healthcare Research and Quality's (AHRQ) report on the decline of inpatient mortality rates for 12 common diagnoses and surgical procedures from 1994-2004. According to AHRQ, the heart attack mortality rate fell by 43 per 1,000 admissions over the period...

  • Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal. Feldman, Debbie Ehrmann; Thivierge, Claude; Guérard, Lise; Déry, Véronique; Kapetanakis, Costas; Lavoie, Gilles; Beck, Eduard J. // CMAJ: Canadian Medical Association Journal;10/16/2001, Vol. 165 Issue 8, p1033 

    Abstract Background Congestive heart failure (CHF) is a common disease requiring admission to hospital among elderly people and is associated with a high mortality rate. The objective of this study was to examine trends in CHF mortality and admissions to hospital in Montreal between 1990 and...

  • Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Aarnoudse, Adrianus L. H. J.; Dieleman, Jeanne P.; Stricker, Bruno H.Ch. // Drug Safety;2007, Vol. 30 Issue 5, p431 

    Background: The safety of digoxin (digitalis) therapy has greatly improved over the past three decades, but recent incidence rates for digoxin intoxication-related hospitalisation are not available. Recent literature suggests that women are at higher risk of digoxin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics